IMPRIMIS Trademark

Trademark Overview

On Friday, December 13, 2013, a trademark application was filed for IMPRIMIS with the United States Patent and Trademark Office. The USPTO has given the IMPRIMIS trademark a serial number of 86143561. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 23, 2023. This trademark is owned by Imprimis Pharmaceuticals, Inc.. The IMPRIMIS trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; ocular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; compounded drug formulation for ocular and intraocular surgery; ocular compounded drug formulations
imprimis

General Information

Serial Number86143561
Word MarkIMPRIMIS
Filing DateFriday, December 13, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 23, 2023
Registration Number5100697
Registration DateTuesday, December 13, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2014

Trademark Statements

Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; ocular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; compounded drug formulation for ocular and intraocular surgery; ocular compounded drug formulations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 23, 2023
Primary Code005
First Use Anywhere DateWednesday, December 31, 2014
First Use In Commerce DateWednesday, December 31, 2014

Trademark Owner History

Party NameImprimis Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameImprimis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameImprimis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Friday, June 23, 2023CANCELLED SEC. 8 (6-YR)
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, December 13, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 27, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, August 2, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 13, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, November 10, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 9, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 25, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 24, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 24, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 24, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 24, 2016NON-FINAL ACTION E-MAILED
Wednesday, February 24, 2016SU - NON-FINAL ACTION - WRITTEN
Wednesday, January 20, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 2, 2015USE AMENDMENT FILED
Friday, January 15, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 2, 2015TEAS STATEMENT OF USE RECEIVED
Wednesday, August 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2015SOU EXTENSION 1 GRANTED
Monday, August 17, 2015SOU EXTENSION 1 FILED
Monday, August 17, 2015TEAS EXTENSION RECEIVED
Tuesday, February 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 24, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, December 24, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 23, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 23, 2014PUBLISHED FOR OPPOSITION
Wednesday, December 3, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 18, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 18, 2014ASSIGNED TO LIE
Friday, October 31, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 23, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 22, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 22, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 22, 2014NON-FINAL ACTION E-MAILED
Saturday, March 22, 2014NON-FINAL ACTION WRITTEN
Friday, March 21, 2014ASSIGNED TO EXAMINER
Saturday, December 28, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 17, 2013NEW APPLICATION ENTERED

Related Keywords

imprimis ocular drug intraocular surgery compounded pharmaceuticals delivery agents formulation formulations